Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MEDRELEAF CORP T.LEAF

"MedReleaf Corp is engaged in the production and sale of cannabis for medical purposes as regulated by the ACMPR, pursuant to its Licences and, in particular, its Markham Commercial Licence."

TSX:LEAF - Post Discussion

MEDRELEAF CORP > Good thing ACB offer didn't go through!!
View:
Post by Skunkworks1 on May 04, 2018 11:34am

Good thing ACB offer didn't go through!!

It would have been low considering the current market conditions for the marijuana stocks and ACB is too much of a loose cannon.  Let LEAF grow on it's own, shareholders will be better off.
Comment by telecaster_400 on May 04, 2018 11:51am
I suspect an offer is still coming
Comment by Skunkworks1 on May 04, 2018 12:16pm
Yes.  Unfortunately you are probably right.  A buyout through WEED would be alot more appealing.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities